PHARMACIE BAUDUIN: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
What changed
PHARMACIE BAUDUIN
NACE 47.730, Retail sale of pharmaceutical products
financial year 2025 compared with 2024filed annual accounts (NBB)
Net result for the year
-€110,917
2024 · -€23,520-€87,397
Equity
-€252,266
2024 · -€141,349-€110,917
Cash
€96,671
2024 · €91,479+€5,192
Balance sheet total
€1.1m
2024 · €1.2m-€94,489
Largest movements
Assets
- Tangible fixed assets -€88,474
down €88,474 (-10.4%), from €849,576 to €761,101
of which Land and buildings: -€72,427
Equity and liabilities
- Profit (loss) carried forward -€110,917
down €110,917 (-47.2%), from -€235,082 to -€345,999
- Debts after one year -€48,632
down €48,632 (-8.2%), from €590,031 to €541,399
- Trade debts +€44,232
up €44,232 (+37.1%), from €119,355 to €163,586
- Other debts +€14,227
up €14,227 (+2.7%), from €522,266 to €536,494
Income statement
- Gross operating margin -€57,968
down €57,968 (-17.6%), from €329,967 to €271,999
- Staff costs +€30,888
up €30,888 (+12.8%), from €242,117 to €273,006
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Result 2024
-€23,520
Gross operating margin
-€57,968
Staff costs
-€30,888
Depreciation
+€825
Other operating charges
-€77
Financial income
-€58
Financial charges
+€772
Taxes
-€1
Result 2025
-€110,917
raises the resultlowers the result
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
From operations
+€52,899
Investment
€0
Financing
-€47,707
Cash 2024
€91,479
From operations (derived)
+€52,899
Net result for the year
-€110,917
Depreciation
+€88,474
Stocks and contracts
+€11,579
Receivables within one year
-€5,147
Deferred charges and accrued income
+€4,774
Trade debts
+€44,232
Tax, wage and social debts
+€4,945
Other debts
+€14,227
Accrued charges and deferred income
+€731
Financing
-€47,707
Debts after one year
-€48,632
Current portion of long-term debt
+€925
Cash 2025
€96,671
brings cash intakes cash out
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €1,180,543 | €1,086,054 | -€94,489 | -8.0% |
| Fixed assets | 21/28 | €849,738 | €761,264 | -€88,474 | -10.4% |
| Tangible fixed assets | 22/27 | €849,576 | €761,101 | -€88,474 | -10.4% |
| Land and buildings | 22 | €766,077 | €693,650 | -€72,427 | -9.5% |
| Plant, machinery and equipment | 23 | €75,625 | €61,661 | -€13,964 | -18.5% |
| Furniture and vehicles | 24 | €7,874 | €5,790 | -€2,084 | -26.5% |
| Financial fixed assets | 28 | €162 | €162 | = | 0.0% |
| Current assets | 29/58 | €330,805 | €324,791 | -€6,014 | -1.8% |
| Stocks and contracts in progress | 3 | €104,210 | €92,630 | -€11,579 | -11.1% |
| Stocks | 30/36 | €104,210 | €92,630 | -€11,579 | -11.1% |
| Amounts receivable within one year | 40/41 | €128,587 | €133,734 | +€5,147 | +4.0% |
| Trade receivables | 40 | €99,176 | €125,088 | +€25,912 | +26.1% |
| Other amounts receivable | 41 | €29,411 | €8,646 | -€20,765 | -70.6% |
| Cash at bank and in hand | 54/58 | €91,479 | €96,671 | +€5,192 | +5.7% |
| Deferred charges and accrued income | 490/1 | €6,529 | €1,755 | -€4,774 | -73.1% |
| Total equity and liabilities | 10/49 | €1,180,543 | €1,086,054 | -€94,489 | -8.0% |
| Equity | 10/15 | -€141,349 | -€252,266 | -€110,917 | -78.5% |
| Contributions | 10/11 | €75,000 | €75,000 | = | 0.0% |
| Reserves | 13 | €18,733 | €18,733 | = | 0.0% |
| Distributable reserves | 133 | €18,733 | €18,733 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€235,082 | -€345,999 | -€110,917 | -47.2% |
| Amounts payable | 17/49 | €1,321,893 | €1,338,321 | +€16,428 | +1.2% |
| Amounts payable after more than one year | 17 | €590,031 | €541,399 | -€48,632 | -8.2% |
| Financial debts | 170/4 | €590,031 | €541,399 | -€48,632 | -8.2% |
| Amounts payable within one year | 42/48 | €730,445 | €794,773 | +€64,328 | +8.8% |
| Current portion of amounts payable after more than one year | 42 | €47,707 | €48,632 | +€925 | +1.9% |
| Trade debts | 44 | €119,355 | €163,586 | +€44,232 | +37.1% |
| Suppliers | 440/4 | €119,355 | €163,586 | +€44,232 | +37.1% |
| Taxes, remuneration and social security | 45 | €41,117 | €46,061 | +€4,945 | +12.0% |
| Taxes | 450/3 | €165 | €298 | +€133 | +80.8% |
| Remuneration and social security | 454/9 | €40,952 | €45,763 | +€4,811 | +11.7% |
| Other amounts payable | 47/48 | €522,266 | €536,494 | +€14,227 | +2.7% |
| Accrued charges and deferred income | 492/3 | €1,417 | €2,149 | +€731 | +51.6% |
| Remuneration, social security and pensions | 62 | €242,117 | €273,006 | +€30,888 | +12.8% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €89,299 | €88,474 | -€825 | -0.9% |
| Other operating charges | 640/8 | €6,017 | €6,094 | +€77 | +1.3% |
| Gross operating margin | 9900 | €329,967 | €271,999 | -€57,968 | -17.6% |
| Operating profit (loss) | 9901 | -€7,467 | -€95,576 | -€88,109 | -1,180% |
| Financial income | 75/76B | €233 | €175 | -€58 | -25.0% |
| Recurring financial income | 75 | €233 | €175 | -€58 | -25.0% |
| Financial charges | 65/66B | €16,138 | €15,366 | -€772 | -4.8% |
| Recurring financial charges | 65 | €16,138 | €15,366 | -€772 | -4.8% |
| Profit (loss) for the period before taxes | 9903 | -€23,372 | -€110,767 | -€87,396 | -374% |
| Income taxes | 67/77 | €148 | €150 | +€1 | +1.0% |
| Profit (loss) for the period | 9904 | -€23,520 | -€110,917 | -€87,397 | -372% |
| Profit (loss) for the period to be appropriated | 9905 | -€23,520 | -€110,917 | -€87,397 | -372% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 21 October 2026 via checked.be.